Replies to post #69516 on Creative Medical Technology Holdings Inc (CELZ)

[justdafactss]

No listing of Alexander Gershman on the LA County Harbor UCLA Medical Center website either:

http://dhs.lacounty.gov/wps/portal/dhs/!ut/p/b1/04_Sj9Q1MjIzMDY2MjfWj9CPykssy0xPLMnMz0vMAfGjzOLdDAwM3P2dgo3cLSwMDBwNXHzcPPxdjbxdDIEKIpEVWJj6OQEVmJj6W3iYGDqbGhDSH64fhaoE3QRTQgoMoAoMcABHA3QTUF3h7mSs7-eRn5uqnxuVY-mZGZAOAK4cc_k!/dl4/d5/L2dJQSEvUUt3QS80SmtFL1o2X0YwMDBHT0JTMkc4ODAwQTBETEZIT0UyUzY1/

In October 2017, based on the safety data from the UCLA trial and peer-reviewed, published results of other clinical trials using the same process, we proceeded with commercialization of the ED procedure. In December 2017, we recruited Dr. Alexander Gershman, Director of The Institute of Advanced Urology at the Cedars-Sinai Medical Tower; Director of Urologic Laparoscopy in the Division of Urology, Harbor-UCLA Medical Center a leading urologists in the Southwestern United States to perform the Caverstem TM procedure to treat erectile dysfunction in patients who do not respond to currently available treatments. In that same month, Dr. Gershman began treating patients with the procedure, which involves extraction of a small amount of bone marrow, concentration of bone marrow derived stem cells, and subsequent administration to the patient within less than 60 minutes
https://www.sec.gov/Archives/edgar/data/1187953/000114420418017967/tv488947_10k.htm

Is the above info sourced from the 3/29/2018 10K filing the truth or a lie?

[escalate]

It appears that the Principal Investigator listed on the peer review study of Caverstem is: Jacob Rajfer, MD University of California, Los Angeles.

https://clinicaltrials.gov/ct2/show/NCT03699943

Isn't he one of the physicians that helped form the basis for the development of the first oral drug for impotence, Viagra ? I'm quite sure.

He has quite a resume so I'd expect the results of the peer review study to be top notch.

https://www.uclahealth.org/jacob-rajfer